Prolonged response to 177Lu-DOTATATE therapy of a bone marrow infiltration in a refractory thymic neuro endocrine tumor.
Invest New Drugs
; 38(4): 1196-1199, 2020 08.
Article
in En
| MEDLINE
| ID: mdl-31650444
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Organometallic Compounds
/
Thymus Neoplasms
/
Octreotide
/
Receptors, Peptide
/
Neuroendocrine Tumors
/
Bone Marrow Neoplasms
/
Radiopharmaceuticals
Type of study:
Prognostic_studies
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
Invest New Drugs
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: